# OnCo record maha-hussain (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/maha-hussain/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "maha-hussain" ;
  schema:name "Maha Hussain"@en ;
  schema:description "Led PROSPER and the PROfound survival analysis, and settled the intermittent hormone therapy question with SWOG 9346."@en ;
  schema:url <https://onco.cc/people/maha-hussain/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Maha_H._Hussain>, <https://orcid.org/0000-0003-0380-9465> ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Hussain%20M%5BAuthor%5D%20prostate%20olaparib%20OR%20enzalutamide> ;
  onco:tag "prostate", "swog", "parp" ;
  schema:jobTitle "Genevieve E. Teuton Professor of Medicine and Deputy Director, Robert H. Lurie Comprehensive Cancer Center of Northwestern University" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:targets <https://onco.cc/targets/parp/>, <https://onco.cc/targets/brca/>, <https://onco.cc/targets/androgen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/> ;
  onco:institutions <https://onco.cc/institutions/northwestern-lurie/> ;
  onco:trials <https://onco.cc/trials/profound/> ;
  schema:affiliation <https://onco.cc/institutions/northwestern-lurie/> .